This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2000-2002.
Company Filing History:
Years Active: 2000-2002
Title: David Lawrence Earnshaw: Innovator in Antibacterial Research
Introduction
David Lawrence Earnshaw is a notable inventor based in Stansted, GB. He has made significant contributions to the field of antibacterial research, holding a total of 2 patents. His work focuses on the development of dnaB polypeptides and their applications in screening for antibacterial compounds.
Latest Patents
Earnshaw's latest patents include innovative methods related to dnaB from Staphylococcus aureus. The first patent provides dnaB polypeptides and polynucleotides encoding these polypeptides, along with methods for producing them through recombinant techniques. Additionally, it outlines methods for utilizing dnaB polypeptides to screen for antibacterial compounds. The second patent mirrors the first, emphasizing the importance of dnaB polypeptides in antibacterial research.
Career Highlights
David Lawrence Earnshaw is associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His expertise in recombinant techniques has positioned him as a key player in the development of antibacterial solutions.
Collaborations
Earnshaw has collaborated with notable coworkers, including Earl William May and Damien McDevitt. Their combined efforts have further advanced the research in antibacterial compounds.
Conclusion
David Lawrence Earnshaw's innovative work in the field of antibacterial research highlights his commitment to developing effective solutions against bacterial infections. His contributions through patents and collaborations continue to impact the scientific community positively.